INTRODUCTION
We have previously shown that cleavage of Hageman factor (HF)' by activated Hageman factor (HFa), (autodigestion) (1) or by kallikrein first yields a two-chain Received for publication 26 February 1982 and in revised form 5 May 1982 . 1 Abbreviations used in this paper: DNS-GGACMK, dansyl-glutamic acid-glycine-arginine-chloro-methyl ketone; HF, Hageman factor; HFa, activated Hageman factor; HFf, Hageman factor fragment; 2-ME, 2-mercaptoethanol. enzyme (HFa) in which a heavy chain of mol wt 52,000 is disulfide linked to a light chain of 28,000 (2) . This form of activated HF, which has the same molecular weight as the native molecule, was first demonstrated functionally by Kaplan and Austen (3) and its structure described by Revak et al. (2) . Further digestion of HFa by kallikrein (4) yields Hageman factor fragment (HFf) that consists of two molecular weight forms of -28,000-30,000 (5) each of which has an active site (1) . Autodigestion of HFa, however, produces not only HFf, but also an active 40,000-mol wt fragment (1) corresponding to one of the intermediate-sized enzymes reported (3) .
In this study we have further investigated the structure of HFf as well as the 40,000-dalton moiety and demonstrate that upon reduction, each possesses a heavy chain of 28,000. The 40,000-dalton enzyme has a light chain of 15,000, whereas the 30,000-dalton form of HFf has a light chain of 2,000. We also demonstrate that the 30,000-dalton form of HFf precedes the formation of a 28,500-dalton form and suggest that the latter molecule possesses a 500-dalton light chain. Our data support the conclusion that HFa formation precedes formation of any of the activated forms of HF (1, 3) and demonstrate that HFf is a two-chain enzyme. The implications of these conclusions upon the mechanism of HF activation and the sites at which cleavage occurs are discussed.
METHODS
Chemicals used in the purification of HF were obtained from sources used previously (6). Other reagents were: H-D-proline-phenylalanine-arginine pNA (H-D-Pro-Phe-Arg pNA) (S2302) (Kabi Group, Inc., Greenwich, CT); ultra pure urea and chymotrypsinogen (Schwartz-Mann Div., Becton, Dickinson & Co., Orangeburg, NY); transferrin, sodium dodecyl sulfate (SDS), tris base, dextran sulfate (M, 500,000), benzamidine, and 2-mercaptoethanol (2-ME) (Sigma Chemical Co., St. Louis, MO); '"I Bolton-Hunter reagent and Na 125I (New England Nuclear, Boston, MA); Kodak XR-5, X-ray film, Tri-X 4 X 5 negative film, and Kodak lanex intensifying screens (Eastman Kodak Co., Rochester, NY); and reagents for electrophoresis and lactoperoxidase/glucose oxidase solid phase enzymobeads (Bio-Rad Laboratories, Richmond, CA). Dansyl-glutamic acid-glycine-arginine-chloro-methyl ketone (DNS-GGACMK) was a generous gift from Dr. Eliot Shaw and Dr. Charles Kettner of Brookhaven National Laboratories, Upton, NY.
HF (6) , HFf, (6), and prekallikrein (7) were purified from human plasma by previously published procedures. Kallikrein was prepared by activation of prekallikrein by HFf and isolated by passage over QAE Sephadex (6) . All plasma proteins were dialyzed into 10 mM sodium phosphate, pH 7.8, and 0.15 sodium chloride before use. Protein concentrations were determined using the method of Lowry et al. (8) Sample buffer was then added with and without 2 Ml of 2-mercaptoethanol and the samples were heated for 2 min at 100°C. After SDS slab gel electrophoresis the gels were transilluminated on a long wave ultraviolet light box. Photographs were made using a red filter and either Polaroid type 57/high speed or Kodak 4177 high speed 4 X 5 film. After photography the gels were stained and dried.
Samples used in two-dimensional gel electrophoresis to determine the structure of HFf and the active species with a mol wt of 40,000 were iodinated using Bolton-Hunter reagent. A sample of 0.6 ml having a protein concentration of 0.21 mg/ml containing HFf and active 40,000 dalton species was made 1% in SDS by the addition of 66 Ml of a 10% SDS solution and placed in a boiling water bath for 3 min. The mixture was added to a glass combi-V-vial (New England Nuclear) in which 250 MCi of Bolton-Hunter reagent had been dried with nitrogen gas. The mixture was incubated for 16 h at room temperature and dialyzed exhaustively in 10 mM sodium phosphate buffer pH 7.8 containing 0.1 M NaCl and 0.005% Triton X-100. Two 15% SDS tube gels (0.4 X 11.5 cm) were loaded with 15 ,l of the sample (2.5 X 105 cpm/tg) and electrophoresed as described above.
The second dimension consisted of a linear acrylamide gradient ranging from 12 to 20%, constructed using a Buchler Universal Mixer, Buchler Instruments, Fort Lee, NJ, with a vibration stirrer attached to a Gilson Minipuls 2 peristaltic pump (Gilson Medical Electronics, Middleton, WI). 11.5 ml of 12% and 20% acrylamide in 0.375 M Tris-HCl, pH 8.8, containing 0.1% SDS and 0.15% N,N,N',N',tetramethyl ethylenediamine were made 0.025% with ammonium persulfate, pumped into the glass form, and allowed to polymerize. A stacking layer of 3% agarose in 0.125 M Tris-HCI, pH 6.8, containing 0.1% SDS with or without 0.5% 2-ME was layered on top. The first dimension tube gel (0.4 X 11.5 cm) containing the protein sample was embedded on the stacking layer by overlaying it with the hot agarose solution. Low molecular weight prestained marker proteins (Bethesda Research Labs, Bethesda, MD) were placed onto Whatman 1 filter paper (Whatman Inc., Paper Div., Clifton, NJ) and embedded adjacent to the first dimension gel.
RESULTS
To assess the kinetics of HFf formation a time course of HF cleavage by kallikrein was performed in the presence of macromolecular dextran sulfate as an initiating surface, and the active enzyme forms produced were labeled with the dansylated active site inhibitor DNS-GGACMK. The fluorescent pattern resulting is shown in Fig. 1 We next digested HF with kallikrein in the fluid phase and isolated the active fragments by QAE Sephadex chromatography as described (6) . Fig. 2 shows nonreduced SDS gels of a mixture of the active fragments of mol wt 40,000, 30,000, and 28,500. Upon reduction, only a 28,000-mol wt band is seen. This pattern of cleavage is seen upon autodigestion of HF upon surfaces (1) or by fluid phase digestion by enzymes such as kallikrein or plasmin (2, 3) . Because the molecular weight of the nonreduced mixture was >28,000 we anticipated seeing low molecular weight bands upon reduction, but did not. We therefore radiolabeled the mixture with 125I using Bolton-Hunter 
DISCUSSION
It has been shown that the native HF is initially activated by a single proteolytic cleavage to yield the two-chained disulfide linked HFa form (10, 11) and that the HFa is then further cleaved to other active species (1, 3) . These include a 40,000-dalton enzyme molecule (1) and HFf, which consists of two active species of mol wt 30,000 and 28,500. Fig. 1 depicts active site generation when surface-bound HF is incubated with kallikrein. The data indicate that HFa is formed initially followed by generation of the 30,000 mol wt form of HFf. The 30,000-dalton form is further cleaved to yield the 28,500 species. This is consistent with our earlier results indicating a sequential formation of active products of lower molecular weights generated from HFa (2); and demonstrates, for the first time, that the lower molecular weight form of HFf (mol wt 28,500) is generated directly from the higher molecular weight form.
Because the molecular weight of HFf is within 2,000 to 3,000 of that of the light chain obtained upon reduction of HFa, it has been proposed that HFf is formed by cleavage outside of a small disulfide bridge. Because HFf is seen as an active doublet, this cleavage must occur at two sites. Fig. 4 is a diagrammatic presentation of the sites at which HF is cleaved to form HFf. An initial cleavage at site 1 within a disulfidelinked portion of the molecule produces HFa. This cleavage is made by either HFa (autodigestion) (1, 6, 12, 13) or by kallikrein (1, 4, 14) . Subsequently, cleavage occurs at site 2, to generate the 30,000-mol wt form of HFf followed by a final cleavage at site 3 to generate the 28,500-mol wt form. Both of these cleavages are proposed to occur to the left of the initial cleavage at site 1 (HFa). A fourth cleavage, which occurs to the left of site 3, can occur, and in the absence of cleavage at sites 2 or 3, will produce the 40,000-dalton active species. Data presented previously (1) indicates that this cleavage is made primarily by HFa. Thus, when HF is incubated with kallikrein in the presence of an initiating surface (e.g., dextran sulfate) 2 3 500 2000 the 40,000-dalton molecule is formed in very minor quantities, if at all (Fig. 1) , presumably because of the efficiency of kallikrein cleavage at sites 2 and 3. However, when HF is incubated with prekallikrein in the fluid phase (in a plastic tube), the 40,000-dalton enzyme is generated (Fig. 2) (1). The data presented in Fig. 3 indicate that the 40,000-dalton enzyme and HFf all consist of a heavy chain of 28,000 daltons disulfide linked to light chains. The light chain of the 40,000-dalton enzyme appears to have a molecular weight of 15,000. It is important to note that a molecular weight of 12,000 was reported (1) for this chain using a nongradient SDS gel electrophoresis system. Molecular weight standards run in both systems generated linear standard curves from which molecular weights of the samples were determined. The difference of molecular weights reported appears to be due to the differing gel systems. A light chain of 2,000 daltons is generated from the left side portion of the HFf position, (Fig. 3.) , and is therefore generated from the 30,000-dalton molecule. A small amount of radiolabeled material is visible at the electrophoretic front of the gel and is generated only from the right portion of the HFf position. No material is present at the front beneath the 40,000-dalton position nor the left portion of the HFf position. Because the material runs at the electrophoretic front, the molecular weight must be <1,000 and might represent the light chain associated with the 28,500-dalton molecule.
Revak et al. (2) have presented a model suggesting that the disulfide bridge area within which activation occurs (site 1) is small and that formation of HFf could occur by cleavage to the left or right of this area. Because HFf has two molecular forms, it is also possible that cleavage occurs at both sites. Cleavage to the right of site 1 would expose a different N-terminus; however, the N-terminal residue exposed by site 1 cleavage is thought to be important for the mechanism of action of serine proteases. It folds into the interior of the protein to form an ion pair with the carboxyl group of the aspartic acid residue adjacent to the active site serine (15) (16) . Cleavage to the right of site 1 would also require that one of these forms have a molecular weight less than that of the light chain of HFa. Because all the forms of activated HF possess a 28,000-dalton disulfide linked chain (1) , and HFa is the precursor of the various active fragmentation products, we propose that the sites of cleavage that produce both active species of HFf as well as the 40,000-dalton enzyme are located to the left of site 1 and outside of the disulfide-linked portion of the molecule at which site 1 cleavage occurs. Revak et al. (10) have also suggested that HF cleavage may proceed nonsequentially to form either HFa by one mechanism (site 1 cleavage) or HFf by a separate mechanism involving cleavage external to the initial disulfide. The active forms resulting were designated a and ,B. Because HF cleavage appears to be sequential, and the various fragmentation products are not significant coagulation factors (2, 5, 10) we feel that HFa should be used to designate the active coagulant enzyme and HFf be reserved for low molecular weight species (28,500-30,000), which function to convert prekallikrein to kallikrein (5) and thereby lead to kinin formation. Other intermediately sized fragments are not seen when normal plasma is activated because the process is kallikrein-dependent, but may be important when prekallikrein-deficient plasma is activated.
